Skip to content
Longterm Wiki
Back

Centre for Long-Term Resilience - Sentinel Bio Grant

web
sentinelbio.org·sentinelbio.org/grant/centre-for-long-term-resilience/

This grant page is primarily relevant to those tracking AI safety and existential risk funding flows, policy ecosystem actors, and the intersection of biosecurity and AI governance through organizations like CLTR.

Metadata

Importance: 25/100press releasereference

Summary

This page documents a grant awarded by Sentinel Bio to the Centre for Long-Term Resilience (CLTR), a UK-based think tank focused on extreme risks including AI and biosecurity. The grant supports CLTR's work on building systemic resilience against catastrophic and existential risks through policy research and government engagement.

Key Points

  • •Sentinel Bio is funding CLTR to advance biosecurity and long-term risk resilience research
  • •CLTR focuses on policy-oriented research addressing catastrophic risks including AI and pandemics
  • •The grant reflects growing funder interest in bridging technical risk research with government policy
  • •CLTR works directly with governments to translate long-term risk thinking into actionable policy
  • •This represents coordination between biosecurity and AI safety funding ecosystems

Cited by 1 page

PageTypeQuality
Centre for Long-Term ResilienceOrganization63.0

Cached Content Preview

HTTP 200Fetched Mar 15, 20261 KB
Centre for Long-Term Resilience – Sentinel Bio 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 

 
 
 

 
 
 

 
 
 
 

 

 
 
 
 
 
 Centre for Long-Term Resilience

 
 
 

 
 
 
 

 
 
 
 
 
 February 2025 
Biosecurity and AI; Nucleic acid governance

 
 
 
 
 
 We provided $400,000 to the Centre for Long-Term Resilience to advance its work on AI-enabled biology, allowing CLTR to further its risk analysis on narrow biological tools and to assess gaps in existing safety frameworks, with the goal of focusing and strengthening policy development efforts. Learn more 

 

 

 Our support will also allow CLTR to rigorously assess the costs and benefits of screening measures for providers of synthetic nucleic acids. We expect this effort to create a robust evidence base to inform policy discourse in the United Kingdom and globally.
Resource ID: 08c2bbf0ff761058 | Stable ID: MTU4ZTA5OD